Since we could not notice any dramatic alteration in the cell cycle of both cell lines after 21 days from transduction and no significant induction of caspase-3 (in MDA-MB-231 cells), we performed experiments to verify any modulation of the proliferative potential of studied breast cancer cells. The gene discussed is CASP3; the disease is breast carcinoma.